Listed

Eton Pharmaceuticals, Inc.

ETONNasdaqCIK 1710340HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$37.6m, Q2 FY2026
Operating income$12.8m, Q2 FY2026
Net income$11.6m, Q2 FY2026
Eton Pharmaceuticals, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m7.0Revenue, Q3 FY2023, three months to 2023-09-30$7.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure7.3Revenue, Q4 FY2023, three months to 2023-12-31$7.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure8.0Revenue, Q1 FY2024, three months to 2024-03-31$8.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure9.1Revenue, Q2 FY2024, three months to 2024-06-30$9.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure10.3Revenue, Q3 FY2024, three months to 2024-09-30$10.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure11.6Revenue, Q4 FY2024, three months to 2024-12-31$11.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure17.3Revenue, Q1 FY2025, three months to 2025-03-31$17.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure18.9Revenue, Q2 FY2025, three months to 2025-06-30$18.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure22.5Revenue, Q3 FY2025, three months to 2025-09-30$22.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure21.3Revenue, Q4 FY2025, three months to 2025-12-31$21.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure24.3Revenue, Q1 FY2026, three months to 2026-03-31$24.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure37.6Revenue, Q2 FY2026, three months to 2026-06-30$37.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure
Cost of revenue$m2.6Cost of revenue, Q3 FY2023, three months to 2023-09-30$2.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure3.7Cost of revenue, Q4 FY2023, three months to 2023-12-31$3.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure3.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$3.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure3.4Cost of revenue, Q2 FY2024, three months to 2024-06-30$3.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure4.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$4.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure5.2Cost of revenue, Q4 FY2024, three months to 2024-12-31$5.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure7.4Cost of revenue, Q1 FY2025, three months to 2025-03-31$7.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure7.0Cost of revenue, Q2 FY2025, three months to 2025-06-30$7.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure14.6Cost of revenue, Q3 FY2025, three months to 2025-09-30$14.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure8.2Cost of revenue, Q4 FY2025, three months to 2025-12-31$8.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure9.5Cost of revenue, Q1 FY2026, three months to 2026-03-31$9.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure12.2Cost of revenue, Q2 FY2026, three months to 2026-06-30$12.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure
Gross profit$m4.4Gross profit, Q3 FY2023, three months to 2023-09-30$4.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure3.6Gross profit, Q4 FY2023, three months to 2023-12-31$3.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure5.0Gross profit, Q1 FY2024, three months to 2024-03-31$5.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure5.6Gross profit, Q2 FY2024, three months to 2024-06-30$5.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure6.3Gross profit, Q3 FY2024, three months to 2024-09-30$6.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure6.5Gross profit, Q4 FY2024, three months to 2024-12-31$6.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure9.9Gross profit, Q1 FY2025, three months to 2025-03-31$9.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure11.9Gross profit, Q2 FY2025, three months to 2025-06-30$11.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure7.9Gross profit, Q3 FY2025, three months to 2025-09-30$7.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure13.1Gross profit, Q4 FY2025, three months to 2025-12-31$13.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure14.7Gross profit, Q1 FY2026, three months to 2026-03-31$14.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure25.4Gross profit, Q2 FY2026, three months to 2026-06-30$25.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure
Research and development$m0.6Research and development, Q3 FY2023, three months to 2023-09-30$615.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure1.0Research and development, Q4 FY2023, three months to 2023-12-31$1.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure0.7Research and development, Q1 FY2024, three months to 2024-03-31$651.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure3.0Research and development, Q2 FY2024, three months to 2024-06-30$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure0.5Research and development, Q3 FY2024, three months to 2024-09-30$505.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure(0.9)Research and development, Q4 FY2024, three months to 2024-12-31−$871.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure1.2Research and development, Q1 FY2025, three months to 2025-03-31$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure3.7Research and development, Q2 FY2025, three months to 2025-06-30$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure1.1Research and development, Q3 FY2025, three months to 2025-09-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure1.8Research and development, Q4 FY2025, three months to 2025-12-31$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure1.9Research and development, Q1 FY2026, three months to 2026-03-31$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure1.0Research and development, Q2 FY2026, three months to 2026-06-30$993.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure
Operating income$m(0.5)Operating income, Q3 FY2023, three months to 2023-09-30−$548.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure(2.0)Operating income, Q4 FY2023, three months to 2023-12-31−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure(0.8)Operating income, Q1 FY2024, three months to 2024-03-31−$800.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure(2.9)Operating income, Q2 FY2024, three months to 2024-06-30−$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure0.5Operating income, Q3 FY2024, three months to 2024-09-30$509.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure0.6Operating income, Q4 FY2024, three months to 2024-12-31$629.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure(0.5)Operating income, Q1 FY2025, three months to 2025-03-31−$470.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure(1.5)Operating income, Q2 FY2025, three months to 2025-06-30−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure(1.4)Operating income, Q3 FY2025, three months to 2025-09-30−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure2.5Operating income, Q4 FY2025, three months to 2025-12-31$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure2.4Operating income, Q1 FY2026, three months to 2026-03-31$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure12.8Operating income, Q2 FY2026, three months to 2026-06-30$12.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure
Interest expense$m0.3Interest expense, Q3 FY2023, three months to 2023-09-30$267.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure0.3Interest expense, Q4 FY2023, three months to 2023-12-31$255.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-14, accession 0001437749-24-007853. Derived: 12-month figure less the 9-month figure.Report this figure0.2Interest expense, Q1 FY2024, three months to 2024-03-31$238.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure0.2Interest expense, Q2 FY2024, three months to 2024-06-30$222.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-07, accession 0001437749-25-025444. Derived: 6-month figure less the 3-month figure.Report this figure0.2Interest expense, Q3 FY2024, three months to 2024-09-30$211.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figurenot reported1.2Interest expense, Q1 FY2025, three months to 2025-03-31$1.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure1.2Interest expense, Q2 FY2025, three months to 2025-06-30$1.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-13, accession 0001437749-26-027684. Derived: 6-month figure less the 3-month figure.Report this figure1.2Interest expense, Q3 FY2025, three months to 2025-09-30$1.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figurenot reported1.1Interest expense, Q1 FY2026, three months to 2026-03-31$1.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure1.0Interest expense, Q2 FY2026, three months to 2026-06-30$1.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-13, accession 0001437749-26-027684. Derived: 6-month figure less the 3-month figure.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure0.2Income tax, Q4 FY2023, three months to 2023-12-31$247.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure0.1Income tax, Q2 FY2024, three months to 2024-06-30$54.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure(0.1)Income tax, Q3 FY2024, three months to 2024-09-30−$126.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure0.1Income tax, Q4 FY2024, three months to 2024-12-31$87.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2025, three months to 2025-03-31$74.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure0.1Income tax, Q2 FY2025, three months to 2025-06-30$66.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure(0.0)Income tax, Q3 FY2025, three months to 2025-09-30−$28.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure(0.1)Income tax, Q4 FY2025, three months to 2025-12-31−$69.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$20.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$140.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure
Net income$m(0.6)Net income, Q3 FY2023, three months to 2023-09-30−$579.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure(2.3)Net income, Q4 FY2023, three months to 2023-12-31−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure(0.8)Net income, Q1 FY2024, three months to 2024-03-31−$811.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure(3.0)Net income, Q2 FY2024, three months to 2024-06-30−$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure0.6Net income, Q3 FY2024, three months to 2024-09-30$627.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure(0.6)Net income, Q4 FY2024, three months to 2024-12-31−$598.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure(1.6)Net income, Q1 FY2025, three months to 2025-03-31−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure(2.6)Net income, Q2 FY2025, three months to 2025-06-30−$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure(1.9)Net income, Q3 FY2025, three months to 2025-09-30−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure1.5Net income, Q4 FY2025, three months to 2025-12-31$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure1.6Net income, Q1 FY2026, three months to 2026-03-31$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure11.6Net income, Q2 FY2026, three months to 2026-06-30$11.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure
Diluted EPS$ per share(0.02)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figurenot reported(0.03)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-05-09, accession 0001437749-24-015697.Report this figure(0.12)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-08-08, accession 0001437749-24-025574.Report this figure0.02Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figurenot reported(0.06)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure(0.10)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure(0.07)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figurenot reported0.05Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure0.35Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure
Basic EPS$ per share(0.02)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figurenot reported(0.03)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure(0.12)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure0.02Basic EPS, Q3 FY2024, three months to 2024-09-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figurenot reported(0.06)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure(0.10)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure(0.07)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figurenot reported0.06Basic EPS, Q1 FY2026, three months to 2026-03-31$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure0.42Basic EPS, Q2 FY2026, three months to 2026-06-30$0.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure

Balance sheet

Cash and equivalents$26.8m, Q2 FY2026
Long-term debt$19.1m, Q2 FY2026
Shareholders' equity$46.6m, Q2 FY2026
Eton Pharmaceuticals, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m22.1Cash and equivalents, Q3 FY2023, at 2023-09-30$22.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0001437749-23-031284.Report this figure21.4Cash and equivalents, FY2023, at 2023-12-31$21.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-18, accession 0001437749-25-008136.Report this figure16.7Cash and equivalents, Q1 FY2024, at 2024-03-31$16.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001437749-24-015697.Report this figure17.7Cash and equivalents, Q2 FY2024, at 2024-06-30$17.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001437749-24-025574.Report this figure20.3Cash and equivalents, Q3 FY2024, at 2024-09-30$20.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure14.9Cash and equivalents, FY2024, at 2024-12-31$14.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-19, accession 0001437749-26-009059.Report this figure17.4Cash and equivalents, Q1 FY2025, at 2025-03-31$17.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure25.4Cash and equivalents, Q2 FY2025, at 2025-06-30$25.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure37.1Cash and equivalents, Q3 FY2025, at 2025-09-30$37.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure25.9Cash and equivalents, FY2025, at 2025-12-31$25.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure19.7Cash and equivalents, Q1 FY2026, at 2026-03-31$19.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure26.8Cash and equivalents, Q2 FY2026, at 2026-06-30$26.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure
Current assets$m27.2Current assets, Q3 FY2023, at 2023-09-30$27.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001437749-23-031284.Report this figure26.8Current assets, FY2023, at 2023-12-31$26.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-18, accession 0001437749-25-008136.Report this figure24.3Current assets, Q1 FY2024, at 2024-03-31$24.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001437749-24-015697.Report this figure25.4Current assets, Q2 FY2024, at 2024-06-30$25.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001437749-24-025574.Report this figure29.7Current assets, Q3 FY2024, at 2024-09-30$29.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure41.0Current assets, FY2024, at 2024-12-31$41.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-19, accession 0001437749-26-009059.Report this figure50.0Current assets, Q1 FY2025, at 2025-03-31$50.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure68.4Current assets, Q2 FY2025, at 2025-06-30$68.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure72.0Current assets, Q3 FY2025, at 2025-09-30$72.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure60.6Current assets, FY2025, at 2025-12-31$60.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure53.2Current assets, Q1 FY2026, at 2026-03-31$53.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure68.6Current assets, Q2 FY2026, at 2026-06-30$68.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure
Total assets$m31.5Total assets, Q3 FY2023, at 2023-09-30$31.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001437749-23-031284.Report this figure31.7Total assets, FY2023, at 2023-12-31$31.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-18, accession 0001437749-25-008136.Report this figure30.8Total assets, Q1 FY2024, at 2024-03-31$30.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001437749-24-015697.Report this figure31.8Total assets, Q2 FY2024, at 2024-06-30$31.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001437749-24-025574.Report this figure35.8Total assets, Q3 FY2024, at 2024-09-30$35.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure76.1Total assets, FY2024, at 2024-12-31$76.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-19, accession 0001437749-26-009059.Report this figure84.0Total assets, Q1 FY2025, at 2025-03-31$84.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure102Total assets, Q2 FY2025, at 2025-06-30$101.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure105Total assets, Q3 FY2025, at 2025-09-30$104.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure92.1Total assets, FY2025, at 2025-12-31$92.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure97.7Total assets, Q1 FY2026, at 2026-03-31$97.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure116Total assets, Q2 FY2026, at 2026-06-30$115.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure
Current liabilities$m10.4Current liabilities, Q3 FY2023, at 2023-09-30$10.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001437749-23-031284.Report this figure16.2Current liabilities, FY2023, at 2023-12-31$16.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-18, accession 0001437749-25-008136.Report this figure15.3Current liabilities, Q1 FY2024, at 2024-03-31$15.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001437749-24-015697.Report this figure18.2Current liabilities, Q2 FY2024, at 2024-06-30$18.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001437749-24-025574.Report this figure19.7Current liabilities, Q3 FY2024, at 2024-09-30$19.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure19.9Current liabilities, FY2024, at 2024-12-31$19.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-19, accession 0001437749-26-009059.Report this figure25.4Current liabilities, Q1 FY2025, at 2025-03-31$25.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure38.6Current liabilities, Q2 FY2025, at 2025-06-30$38.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure44.2Current liabilities, Q3 FY2025, at 2025-09-30$44.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure38.5Current liabilities, FY2025, at 2025-12-31$38.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure44.2Current liabilities, Q1 FY2026, at 2026-03-31$44.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure45.1Current liabilities, Q2 FY2026, at 2026-06-30$45.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure
Total liabilities$m14.6Total liabilities, Q3 FY2023, at 2023-09-30$14.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001437749-23-031284.Report this figure16.3Total liabilities, FY2023, at 2023-12-31$16.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-18, accession 0001437749-25-008136.Report this figure15.3Total liabilities, Q1 FY2024, at 2024-03-31$15.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001437749-24-015697.Report this figure18.4Total liabilities, Q2 FY2024, at 2024-06-30$18.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001437749-24-025574.Report this figure19.9Total liabilities, Q3 FY2024, at 2024-09-30$19.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure51.7Total liabilities, FY2024, at 2024-12-31$51.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-19, accession 0001437749-26-009059.Report this figure59.6Total liabilities, Q1 FY2025, at 2025-03-31$59.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure77.7Total liabilities, Q2 FY2025, at 2025-06-30$77.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure81.4Total liabilities, Q3 FY2025, at 2025-09-30$81.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure66.0Total liabilities, FY2025, at 2025-12-31$66.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure67.1Total liabilities, Q1 FY2026, at 2026-03-31$67.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure69.2Total liabilities, Q2 FY2026, at 2026-06-30$69.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure
Long-term debt$m4.2Long-term debt, Q3 FY2023, at 2023-09-30$4.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-09, accession 0001437749-23-031284.Report this figure0.0Long-term debt, FY2023, at 2023-12-31$0. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-03-18, accession 0001437749-25-008136.Report this figurenot reportednot reportednot reported29.8Long-term debt, FY2024, at 2024-12-31$29.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-19, accession 0001437749-26-009059.Report this figure30.0Long-term debt, Q1 FY2025, at 2025-03-31$30.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure27.4Long-term debt, Q2 FY2025, at 2025-06-30$27.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure27.6Long-term debt, Q3 FY2025, at 2025-09-30$27.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure21.8Long-term debt, FY2025, at 2025-12-31$21.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure18.9Long-term debt, Q1 FY2026, at 2026-03-31$18.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure19.1Long-term debt, Q2 FY2026, at 2026-06-30$19.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure
Current portion of debt$m1.5Current portion of debt, Q3 FY2023, at 2023-09-30$1.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-09, accession 0001437749-23-031284.Report this figure5.4Current portion of debt, FY2023, at 2023-12-31$5.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-18, accession 0001437749-25-008136.Report this figure5.0Current portion of debt, Q1 FY2024, at 2024-03-31$5.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-09, accession 0001437749-24-015697.Report this figure4.7Current portion of debt, Q2 FY2024, at 2024-06-30$4.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-08, accession 0001437749-24-025574.Report this figure4.1Current portion of debt, Q3 FY2024, at 2024-09-30$4.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-19, accession 0001437749-26-009059.Report this figurenot reported2.8Current portion of debt, Q2 FY2025, at 2025-06-30$2.8m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure2.8Current portion of debt, Q3 FY2025, at 2025-09-30$2.8m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure8.8Current portion of debt, FY2025, at 2025-12-31$8.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-19, accession 0001437749-26-009059.Report this figure11.8Current portion of debt, Q1 FY2026, at 2026-03-31$11.8m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure8.8Current portion of debt, Q2 FY2026, at 2026-06-30$8.8m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure
Shareholders' equity$m16.9Shareholders' equity, Q3 FY2023, at 2023-09-30$16.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure15.5Shareholders' equity, FY2023, at 2023-12-31$15.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-19, accession 0001437749-26-009059.Report this figure15.5Shareholders' equity, Q1 FY2024, at 2024-03-31$15.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0001437749-25-025444.Report this figure13.5Shareholders' equity, Q2 FY2024, at 2024-06-30$13.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure16.0Shareholders' equity, Q3 FY2024, at 2024-09-30$16.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure24.4Shareholders' equity, FY2024, at 2024-12-31$24.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure24.5Shareholders' equity, Q1 FY2025, at 2025-03-31$24.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure24.0Shareholders' equity, Q2 FY2025, at 2025-06-30$24.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure23.1Shareholders' equity, Q3 FY2025, at 2025-09-30$23.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure26.2Shareholders' equity, FY2025, at 2025-12-31$26.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure30.6Shareholders' equity, Q1 FY2026, at 2026-03-31$30.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure46.6Shareholders' equity, Q2 FY2026, at 2026-06-30$46.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure

Cash flow

Operating cash flow$7.3m, Q2 FY2026
Capital expenditure−$5.0k, Q2 FY2026
Eton Pharmaceuticals, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m0.9Operating cash flow, Q3 FY2023, three months to 2023-09-30$873.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001437749-24-034567. Derived: 9-month figure less the 6-month figure.Report this figure0.4Operating cash flow, Q4 FY2023, three months to 2023-12-31$387.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure(2.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure1.3Operating cash flow, Q2 FY2024, three months to 2024-06-30$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001437749-25-025444. Derived: 6-month figure less the 3-month figure.Report this figure3.0Operating cash flow, Q3 FY2024, three months to 2024-09-30$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001437749-25-033619. Derived: 9-month figure less the 6-month figure.Report this figure(0.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$765.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure2.1Operating cash flow, Q1 FY2025, three months to 2025-03-31$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure8.0Operating cash flow, Q2 FY2025, three months to 2025-06-30$8.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001437749-26-027684. Derived: 6-month figure less the 3-month figure.Report this figure12.0Operating cash flow, Q3 FY2025, three months to 2025-09-30$12.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001437749-25-033619. Derived: 9-month figure less the 6-month figure.Report this figure(11.6)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$11.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure7.4Operating cash flow, Q1 FY2026, three months to 2026-03-31$7.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure7.3Operating cash flow, Q2 FY2026, three months to 2026-06-30$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001437749-26-027684. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001437749-24-034567. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$14.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0001437749-25-016475.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001437749-25-025444. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001437749-25-033619. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$12.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001437749-26-027684. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q3 FY2025, three months to 2025-09-30$284.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001437749-25-033619. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$49.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001437749-26-009059. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$75.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure(0.0)Capital expenditure, Q2 FY2026, three months to 2026-06-30−$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001437749-26-027684. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)32.79m, Q2 FY2026
Eton Pharmaceuticals, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares25.4Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3025,365,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001437749-23-031284.Report this figure0.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3125,525 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001437749-24-015697.Report this figure0.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3025,983 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001437749-24-025574.Report this figure0.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3025,719 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001437749-24-034567.Report this figure0.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3125,763 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001437749-24-015697.Report this figure0.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3025,778 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001437749-24-025574.Report this figure26.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3026,550,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure26.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3126,886,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure26.9Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3026,893,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure26.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3026,893,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001437749-25-033619.Report this figure31.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3131,547,220 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001437749-26-017064.Report this figure32.8Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3032,787,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure

Shares outstanding: 28.58mShares outstanding, period not labelled, at 2026-08-1128,583,135 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001437749-26-027684.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.